Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Email alerts

Application overview

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal
UNC Libraries
Date
2024-10-22
Source
OpenAlex
DOI
10.17615/kg31-1v38
PubMed
Unavailable

Authors

MottSarah E.Clyde W. HodgeJessica L. HoffmanMaria Echeveste SanchezChristian S. RollisonMargaret W. HighDevin P. EffingerMelissa A. HermanSarah N. MageeDaniel ToedtSema G. Quadir
Watch author

Derived topics and classifications

psilocin Receptor Pharmacology Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration2024-10-22

Related papers

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy.Frontiers in psychology · 2026-01-01Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.ClinicalTrials.gov · 2025-09-10Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?Journal of Humanistic Psychology · 2025-03-21B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-12The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic ReviewJournal of Sociology Psychology & Religious Studies · 2023-11-06Expectancies for Subjective and Antidepressant Effects in Psilocybin UsersJournal of Humanistic Psychology · 2023-09-22Psychedelic Drug Therapy for Mental Disorders?Open Journal of Medical Psychology · 2023-01-01